The Discounted Cash Flow (DCF) valuation of GW Pharmaceuticals PLC (GWPH) is (674.80) USD. With the latest stock price at 218.96 USD, the upside of GW Pharmaceuticals PLC based on DCF is -408.2%.
Based on the latest price of 218.96 USD and our DCF valuation, GW Pharmaceuticals PLC (GWPH) is a sell. selling GWPH stocks now will result in a potential gain of 408.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.5% - 9.6% | 8.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (1,762.73) - (426.28) | (674.80) |
| Upside | -905.0% - -294.7% | -408.2% |